Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB
- Authors:
- Sha Yi
- Yan Chen
- Lu Wen
- Lijing Yang
- Guohui Cui
View Affiliations
Affiliations: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China
- Published online on: July 18, 2012 https://doi.org/10.3892/ijmm.2012.1067
-
Pages:
877-883
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Oridonin has been utilized for the treatment of various human diseases due to its anti-inflammatory, antibacterial and antitumor effects. However, the precise mechanisms induced by oridonin in human erythroleukemia are yet to be clarified. The present study aimed to elucidate possible oridonin‑induced apoptotic mechanisms in OCIM2 cells, as well as the possible mechanisms whereby OCIM2 cells are relatively resistant to oridonin. Results in the present study showed that oridonin significantly inhibited OCIM2 and OCI-AML3 cell proliferation in a dose- and time-dependent manner, while expressing a much higher IC50 in OCIM2, compared to OCI-AML3. These results also indicated that oridonin induced OCIM2 cell apoptosis, associated with p65 and Bax, while activating caspases-9, -6 and -3. However, p65 was only partly translocated into the nucleus, while most of the p65 was retained in the cytoplasm. Moreover, nucleoporin 214 (Nup214) and nucleoporin 88 (Nup88) were downregulated at the transcriptional and protein levels, subsequent to oridonin treatment. Taken together, these data suggest that oridonin has the potential to induce OCIM2 cell-apoptosis, involving NF-κB activation, whereas the downregulation of Nup88 and Nup214 may protect OCIM2 through the regulation of the nucleocytoplasmic transport of p65.
View References
1.
|
FP SantosCE Bueso-RamosF RavandiAcute
erythroleukemia: diagnosis and managementExpert Rev
Hematol3705718201010.1586/ehm.10.6221091147
|
2.
|
MS HaydenS GhoshShared principles in
NF-kappaB
signalingCell132344362200810.1016/j.cell.2008.01.02018267068
|
3.
|
KM RyanMK ErnstNR RiceKH VousdenRole of
NF-kappaB in p53-mediated programmed cell
deathNature404892897200010.1038/3500913010786798
|
4.
|
V BaudM KarinIs NF-kappaB a good target
for cancer therapy?Hopes and pitfalls Nat Rev Drug
Discov83340200910.1038/nrd278119116625
|
5.
|
ND PerkinsTD GilmoreGood cop, bad cop: the
different faces of NF-kappaBCell Death
Differ13759772200610.1038/sj.cdd.440183816410803
|
6.
|
K WeisNucleocytoplasmic transport: cargo
trafficking across the borderCurr Opin Cell
Biol14328335200210.1016/S0955-0674(02)00337-X12067655
|
7.
|
VE GouldA OrucevicH ZentgrafP GattusoN
MartinezA AlonsoNup88 (karyoporin) in human malignant neoplasms and
dysplasias: correlations of immunostaining of tissue sections,
cytologic smears, and immunoblot analysisHum
Pathol33536544200210.1053/hupa.2002.124785
|
8.
|
VE GouldN MartinezA OrucevicJ SchneiderA
AlonsoA novel, nuclear pore-associated, widely distributed molecule
overexpressed in oncogenesis and developmentAm J
Pathol15716051613200010.1016/S0002-9440(10)64798-011073820
|
9.
|
A EmterlingJ SkoglundG
ArbmanClinicopathological significance of Nup88 expression in
patients with colorectal
cancerOncology64361369200310.1159/00007029412759533
|
10.
|
M FornerodM OhnoM YoshidaIW MattajCRM1 is
an export receptor for leucine-rich nuclear export
signalsCell9010511060199710.1016/S0092-8674(00)80371-29323133
|
11.
|
F GaoQ TangP YangY FangW LiY WuApoptosis
inducing and differentiation enhancement effect of oridonin on the
all-trans-retinoic acid-sensitive and -resistant acute
promyelocytic leukemia cellsInt J Lab
Hematol32e114e122201010.1111/j.1751-553X.2009.01147.x
|
12.
|
GB ZhouSJ ChenZY WangZ ChenBack to the
future of oridonin: again, compound from medicinal herb shows
potent antileukemia efficacies in vitro and in vivoCell
Res17274276200710.1038/cr.2007.2117426700
|
13.
|
FH GaoF LiuW WeiOridonin induces apoptosis
and senescence by increasing hydrogen peroxide and glutathione
depletion in colorectal cancer cellsInt J Mol
Med29649655201222294162
|
14.
|
Z JiQJ TangJS ZhangY YangYF LiuYJ
PanOridonin-induced apoptosis in SW620 human colorectal
adenocarcinoma cellsOncol Lett213031307201122848306
|
15.
|
S GhoshM KarinMissing pieces in the
NF-kappaB
puzzleCell109SupplS81S96200210.1016/S0092-8674(02)00703-111983155
|
16.
|
V KirkinS JoosM ZornigThe role of Bcl-2
family members in tumorigenesisBiochim Biophys
Acta1644229249200410.1016/j.bbamcr.2003.08.00914996506
|
17.
|
NA ThornberryCaspases: key mediators of
apoptosisChem
Biol5R97R103199810.1016/S1074-5521(98)90615-99578633
|
18.
|
R BernadD EngelsmaH SandersonH
PickersgillM FornerodNup214-Nup88 nucleoporin subcomplex is
required for CRM1-mediated 60 S preribosomal nuclear exportJ Biol
Chem2811937819386200610.1074/jbc.M51258520016675447
|
19.
|
S HuttenRH KehlenbachNup214 is required
for CRM1-dependent nuclear protein export in vivoMol Cell
Biol2667726785200610.1128/MCB.00342-0616943420
|
20.
|
AE UvP RothN XylourgidisA WickbergR
CanteraC Samakovlismembers only encodes a Drosophila
nucleoporin required for rel protein import and immune response
activationGenes Dev1419451957200010921908
|
21.
|
P RothN XylourgidisN SabriA UvM FornerodC
SamakovlisThe Drosophila nucleoporin DNup88 localizes
DNup214 and CRM1 on the nuclear envelope and attenuates
NES-mediated nuclear exportJ Cell Biol1637017062003
|
22.
|
N XylourgidisP RothN SabriV TsarouhasC
SamakovlisThe nucleoporin Nup214 sequesters CRM1 at the nuclear rim
and modulates NFkappaB activation in DrosophilaJ Cell
Sci11944094419200610.1242/jcs.0320117032737
|